Collaborations & Alliances
Related Searches:
Filter by:
421 - 435 of 1089 results
May 24, 2011
Xcellerex, Inc. and Gallus BioPharmaceuticals, LLC have entered into a collaboration to provide Gallus with expanded cGMP biomanufacturing capacity using Xcellerex’s FlexFactory GMP manufacturing platform suite.
Read More »
May 18, 2011
Goodwin Biotechnology, Inc. (GBI) and Rafagen, Inc. have entered a collaboration agreement for cell line engineering and biological contract manufacturing.
Read More »
May 17, 2011
Tekmira Pharmaceuticals has expanded its multi-year collaboration with Bristol-Myers Squibb to include newly developed Tekmira proprietary lipid nanoparticle (LNP) formulations for delivery to tumors and other tissues outside the liver.
Read More »
May 16, 2011
Data analysis services to speed discovery programs
Read More »
May 13, 2011
Paladin Labs has entered into a licensing and distribution agreement with Elan Corp. under which Paladin has exclusive Canadian rights to market and sell (upon regulatory approval) Elan’s controlled release hydrocodone product for the treatment of m
Read More »
May 12, 2011
Oncolytics Biotech has entered into a commercial supply agreement with SAFC, a division of Sigma-Aldrich Corp., for the commercial manufacture of Oncolytics’ reovirus, Reolysin.
Read More »
May 12, 2011
SilenceSelect tech to assist CNS research
Read More »
May 11, 2011
Halozyme Therapeutics and ViroPharma have signed a worldwide exclusive licensing agreement for the use of rHuPH20 (recombinant human hyaluronidase) for the development of a subcutaneous formulation of Cinryze.
Read More »
May 11, 2011
Immunologix and DavosPharma have formed a strategic alliance under which DavosPharma will represent and market human antibodies produced by Immunologix.
Read More »
May 10, 2011
Pfenex, Inc. has entered a three-year strategic collaboration with MedImmune, the global biologics business of AstraZeneca, granting MedImmune non-exclusive access to Pfenex Expression Technology and resources for the development of bioprocesses for thera
Read More »
May 9, 2011
Evotec AG has achieved a twelfth milestone in its research alliance with Boehringer Ingelheim triggering a $2.9 million payment to Evotec.
Read More »
May 3, 2011
Icagen and Pfizer have entered into a collaboration with the Yale School of Medicine to investigate potential new pain compounds identified by Icagen and Pfizer in their existing collaboration.
Read More »
April 29, 2011
PSI to gain preferred access to VitalDose EVA for early-stage projects
Read More »
April 29, 2011
Stability storage services added to Velesco's development offerings.
Read More »
April 26, 2011
Pharmacyclics, Inc. has received a $7 million milestone payment from Les Laboratoires Servier (Servier) for its histone deacetylase (HDAC) inhibitor, PCI-24781 / S 78454.
Read More »
421 - 435 of 1089 results
